Breaking News Instant updates and real-time market news.

NBIX

Neurocrine

$76.64

-2.39 (-3.02%)

16:31
05/20/19
05/20
16:31
05/20/19
16:31

Neurocrine initiated with an Outperform at Credit Suisse

Credit Suisse analyst Evan Seigerman initiated Neurocrine with an Outperform rating and a $95 price target, calling the stock a Top Pick - SMID Cap. Seigerman believes Neurocrine's Ingrezza is "the best-in-class treatment" for tardive dyskinesia, or TD, and he expects it will drive revenue and earnings growth over the next few years. He also believes the company's pipeline has underappreciated upside potential, with assets for Parkinson's disease and congenital adrenal hyperplasia.

  • 22

    May

NBIX Neurocrine
$76.64

-2.39 (-3.02%)

04/22/19
JPMS
04/22/19
UPGRADE
Target $106
JPMS
Overweight
JPMorgan upgrades Neurocrine to Overweight after 15% pullback
JPMorgan analyst Anupam Rama upgraded Neurocrine Biosciences to Overweight from Neutral and raised his price target for the shares to $106 from $100. The stock is down ~15% from the mid-January highs, Rama tells investors in a research note. The analyst, however, says his "multiple proprietary analyses" since January "underscore the solid fundamentals of Neurocrine," For example, his March U.S. tardive dyskinesia physician survey shows a preference for Ingrezza over Austedo, anticipated overall branded market growth, and Ingrezza continuing to gain dominant market share over the next 12-24 months. Further, Rama believes the Q1 consensus estimate for Ingrezza could be beatable.
04/26/19
EVER
04/26/19
NO CHANGE
EVER
Neurocrine shares defended at Evercore ISI
04/29/19
CANT
04/29/19
NO CHANGE
Target $127
CANT
Overweight
Neurocrine selloff an opportunity for 'several reasons,' says Cantor Fitzgerald
Neurocrine Biosciences recently traded lower as Ingrezza was put on updated 2019 National Preferred Formulary exclusions list that Express Scripts (ESRX) published, Cantor Fitzgerald analyst Charles Duncan tells investors in a research note. The analyst sees the selloff as an "opportunity for longer-horizon investors for several reasons." The exclusion is not immediate, and will also have little impact on Ingrezza sales as Express Scripts accounts for less than 1% of the drugs revenue, Duncan writes. He believes Ingrezza will continue to grow with "deepening penetration" of the tardive dyskinesia market as the "pharmaco-economic benefits continue to be realized." The analyst reiterates an Overweight rating on Neurocrine with a $127 price target.
05/14/19
LEHM
05/14/19
NO CHANGE
Target $25
LEHM
Overweight
Myovant Sciences selloff overdone after report of relugolix data, says Barclays
Barclays analyst Geoffrey Meacham said he thinks the selloff in shares of Myovant Sciences (MYOV) is overdone after the release of relugolix phase 3 uterine fibroids data. He believes investors are "selling the news" and he still believes relugolix has a comparable profile to AbbVie (ABBV) and Neurocrine's (NBIX) elagolix and will find a place in the market given what he sees as positive data reported this morning, Meacham tells investors. He keeps an Overweight rating and $25 price target on Myovant shares, which are down 26% to $12.67 in early afternoon trading.

TODAY'S FREE FLY STORIES

14:55
06/18/19
06/18
14:55
06/18/19
14:55
General news
FOMC forecast preview: »

FOMC forecast preview:…

APC

Anadarko

$70.00

0.21 (0.30%)

14:52
06/18/19
06/18
14:52
06/18/19
14:52
Periodicals
Anadarko gives go-ahead on $20B LNG export project in Mozambique, Reuters says »

Anadarko Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSP

E.W. Scripps

$15.02

0.01 (0.07%)

, CBS

CBS

$49.38

0.22 (0.45%)

14:50
06/18/19
06/18
14:50
06/18/19
14:50
Hot Stocks
E.W. Scripps reports consent decree to settle DOJ civil case »

In a regulatory filing,…

SSP

E.W. Scripps

$15.02

0.01 (0.07%)

CBS

CBS

$49.38

0.22 (0.45%)

FOXA

Fox Corp.

$36.59

0.44 (1.22%)

FOX

Fox Corp.

$36.23

0.44 (1.23%)

TGNA

Tegna

$15.09

0.22 (1.48%)

SBGI

Sinclair Broadcast

$53.51

0.01 (0.02%)

NXST

Nexstar

$102.72

2.31 (2.30%)

MDP

Meredith

$53.04

0.88 (1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 25

    Jun

  • 06

    Aug

  • 08

    Aug

  • 13

    Nov

WFC

Wells Fargo

$46.25

0.99 (2.19%)

, GS

Goldman Sachs

$195.72

4.98 (2.61%)

14:50
06/18/19
06/18
14:50
06/18/19
14:50
Periodicals
Wells Fargo dismissed from VRDO lawsuit, Reuters reports »

Wells Fargo & Co…

WFC

Wells Fargo

$46.25

0.99 (2.19%)

GS

Goldman Sachs

$195.72

4.98 (2.61%)

JPM

JPMorgan

$111.21

2.01 (1.84%)

BAC

Bank of America

$28.72

0.79 (2.83%)

BCS

Barclays

$7.59

0.09 (1.20%)

C

Citi

$68.12

1.59 (2.39%)

RY

Royal Bank of Canada

$78.69

1.45 (1.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 09

    Jul

  • 13

    Jul

  • 13

    Jul

  • 15

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 17

    Jul

  • 06

    Aug

  • 13

    Aug

  • 21

    Aug

  • 12

    Oct

ADBE

Adobe

$278.26

2.67 (0.97%)

14:49
06/18/19
06/18
14:49
06/18/19
14:49
Options
Adobe options imply 5.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

RARX

RA Pharmaceuticals

$22.36

-0.38 (-1.67%)

14:48
06/18/19
06/18
14:48
06/18/19
14:48
Recommendations
RA Pharmaceuticals analyst commentary  »

RA Pharmaceuticals price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

FITB

Fifth Third

$27.53

0.58 (2.15%)

14:46
06/18/19
06/18
14:46
06/18/19
14:46
Hot Stocks
Fifth Third boosts quarterly dividend 9% to 24c »

Fifth Third Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 29

    Aug

MAS

Masco

$38.12

0.22 (0.58%)

14:42
06/18/19
06/18
14:42
06/18/19
14:42
Recommendations
Masco analyst commentary  »

Masco sale of cyclical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$31.69

0.82 (2.66%)

14:25
06/18/19
06/18
14:25
06/18/19
14:25
Options
Skechers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLT

Poly

$44.03

0.98 (2.28%)

14:25
06/18/19
06/18
14:25
06/18/19
14:25
Conference/Events
Poly participates in an investor webinar with Northland Capital Markets »

Northland Capital Markets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 18

    Jun

  • 28

    Jun

  • 13

    Nov

14:25
06/18/19
06/18
14:25
06/18/19
14:25
Conference/Events
Senate Commerce, Science & Transportation Committee to hold a hearing »

The Subcommittee on…

GIII

G-III Apparel

$26.38

0.71 (2.77%)

14:18
06/18/19
06/18
14:18
06/18/19
14:18
Hot Stocks
G-III Apparel up 6% after CEO buys over $1M worth of shares »

G-III Apparel Group CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 09

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
06/18/19
06/18
14:17
06/18/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
06/18/19
06/18
14:16
06/18/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPW

DPW Holdings

$0.14

-0.003 (-2.13%)

14:15
06/18/19
06/18
14:15
06/18/19
14:15
Hot Stocks
Breaking Hot Stocks news story on DPW Holdings  »

Digital Power trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jul

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$292.33

2.87 (0.99%)

14:06
06/18/19
06/18
14:06
06/18/19
14:06
Periodicals
USTR says China tariffs only recourse given dialogue has failed, Reuters says »

U.S. Trade Representative…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$292.33

2.87 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARWR

Arrowhead

$27.10

0.67 (2.54%)

14:05
06/18/19
06/18
14:05
06/18/19
14:05
Options
Arrowhead call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

DPW

DPW Holdings

$0.14

-0.003 (-2.13%)

14:01
06/18/19
06/18
14:01
06/18/19
14:01
Hot Stocks
DPW Holdings announces deal with senior lender to refinance outstanding debt »

DPW Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jul

CMCSA

Comcast

$43.10

0.54 (1.27%)

, CHTR

Charter

$396.65

2.64 (0.67%)

13:58
06/18/19
06/18
13:58
06/18/19
13:58
Hot Stocks
Comcast says Charter, Cox join 'On Addressability' initiative »

Comcast Advertising, the…

CMCSA

Comcast

$43.10

0.54 (1.27%)

CHTR

Charter

$396.65

2.64 (0.67%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

CVS

CVS Health

$54.84

0.32 (0.59%)

13:55
06/18/19
06/18
13:55
06/18/19
13:55
Conference/Events
CVS Health participates in a conference call with JPMorgan »

Healthcare Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 18

    Jun

GOOG

Alphabet

$1,107.00

14.75 (1.35%)

, GOOGL

Alphabet Class A

$1,110.00

17.29 (1.58%)

13:54
06/18/19
06/18
13:54
06/18/19
13:54
Periodicals
Google tells Bloomberg issues with calendar resolved »

Google said in a…

GOOG

Alphabet

$1,107.00

14.75 (1.35%)

GOOGL

Alphabet Class A

$1,110.00

17.29 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 09

    Jul

  • 10

    Jul

  • 27

    Oct

NVO

Novo Nordisk

$52.19

1.19 (2.33%)

13:52
06/18/19
06/18
13:52
06/18/19
13:52
Hot Stocks
Novo Nordisk sNDA for expanded Victoza age range approved by FDA »

A letter posted on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

DPW

DPW Holdings

$0.14

-0.002 (-1.42%)

13:46
06/18/19
06/18
13:46
06/18/19
13:46
Hot Stocks
Breaking Hot Stocks news story on DPW Holdings  »

Digital Power trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jul

ROX

Castle Brands

$0.52

0.0046 (0.89%)

13:45
06/18/19
06/18
13:45
06/18/19
13:45
Recommendations
Castle Brands analyst commentary at Barrington »

Castle Brands Q4 results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XON

Intrexon

$8.61

1.02 (13.44%)

13:45
06/18/19
06/18
13:45
06/18/19
13:45
Options
Intrexon call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.